Get started
Author

Fiona Rees

Practical Pharmacist-Led Interventions to Improve Antimicrobial Stewardship in Ghana, Tanzania, Uganda and Zambia
2021 · Frances Kerr, Israel Abebrese Sefah, et al. · Pharmacy · 28
PDF
Appropriateness of small molecule agents for patients with IBD of childbearing age – a RAND/UCLA appropriateness panel
2024 · Christian Selinger, Robyn Laube, et al. · Therapeutic Advances in Gastroenterology · 9
The 2026 IBD UK Standards of healthcare service design and delivery for adults and children living with Crohn’s disease and ulcerative colitis
2026 · Christopher A Lamb, Catherine Picton, et al. · BMJ Open Gastroenterology · 6
PDF
Effectiveness and safety of upadacitinib in a real-world cohort of patients with Crohn’s disease in the UK: a multicentre retrospective cohort study
2025 · Yaa Danso, Chandni Radia, et al. · BMJ Open Gastroenterology · 5
PDF
Comparative analysis of inflammatory bowel disease (IBD) patient- and service-reported quality of care using 2019 and 2023 UK benchmarking data from more than 26 000 adult patient respondents and 154 IBD services
2026 · A Barney Hawthorne, Paul Christiansen, et al. · Journal of Crohn s and Colitis · 3
P514 Beyond the First Attempt: A Multi-Centre UK Analysis of Second JAK Inhibitor Use in Ulcerative Colitis
2024 · Y Danso, C Radia, et al. · Journal of Crohn s and Colitis · 3
PDF
Is 2nd JAKi treatment for UC worth the effort? A retrospective, multi-centre UK study
2025 · Chandni Radia, Yaa Danso, et al. · Journal of Crohn s and Colitis · 2
P604 Can we reduce intravenous monoclonal antibody observation times without compromising patient safety? A single centre retrospective observational study
2020 · F REES, A Packham, et al. · Journal of Crohn s and Colitis · 1
P236 IBD-TAPAS: a UK survey to assess IBD therapy access pathways and selection
2026 · Rubin George, Fiona Rees, et al. · E-Posters
PDF
P213 Ustekinumab originator to biosimilar switch: no adverse impact on inflammatory bowel disease control and well tolerated in a multicentre study
2026 · Esha Sharma, Mohammed Allah-Ditta, et al. · E-Posters
PDF
THU-540 Early UK experience with elafibranor in primary biliary cholangitis: a multicentre pharmacist-led review
2026 · Arron Jones, Robert Elliot-Cooke, et al. · Journal of Hepatology
DOP087 Determining the care quality perception gap between patients and service providers: Comparative analysis of 2019 and 2023 UK IBD benchmarking data from more than 26,000 adult patients and 154 IBD services
2026 · A B Hawthorne, P Christiansen, et al. · Journal of Crohn s and Colitis
PDF
P1139 Switching from ustekinumab originator to biosimilar: No adverse impact on inflammatory bowel disease control and well tolerated by patients in a UK multicentre study
2026 · E Sharma, M Allah-Ditta, et al. · Journal of Crohn s and Colitis
P34 Initial clinical response and safety of elafibranor in primary biliary cholangitis: a multi-centre pharmacist-led real-world evaluation
2025 · Arron Jones, Kate Greener, et al.
P253 Does the development of a pharmacy clinic improve PBC patient care? A single-service evaluation
2025 · Darya Grawe, Khaleel Jamil, et al.
P102 Does a joint Doctor-Pharmacist clinic improve outcomes for autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC) patients? a retrospective single-centre pilot
2024 · Fiona Rees, Ioanna Mavrantoni, et al.
THU-045 Medicines optimisation in patients admitted with hepatic encephalopathy in UK centres
2024 · Connor Thompson, Arron Jones, et al. · Journal of Hepatology
P48 Extended 6-month stability data in blister packs demonstrated for hepatitis C medications
2024 · Fiona Rees, Bobbie Mcvey, et al. · Poster presentations
P361 Improving safety of prescribing practices in alcohol withdrawal in advanced liver disease
2024 · Tessa Lawton, Fiona Rees, et al. · Poster presentations
P133 Appropriateness of small molecule agents for patients with IBD of childbearing age – a RAND appropriateness panel
2024 · Christian Selinger, Robyn Laube, et al. · Poster presentations
O2 Beyond the first attempt: a multi-centre UK analysis of second JAK inhibitor use in ulcerative colitis
2024 · Yaa Danso, Chadni Radia, et al. · Oral Presentations
P768 Appropriateness of small molecule agents for patients with IBD of childbearing age – a RAND appropriateness panel
2024 · C P Selinger, R Laube, et al. · Journal of Crohn s and Colitis
PDF
P117 IBD in the elderly: the increasing need to adapt our MDT
2023 · Flora Kokwaro, Ningyu Chai, et al. · Poster presentations
P324 Upskilling pharmacy technicians support robust and cost-effective specialist gastroenterology services. A single-centre prospective study
2022 · Fiona Rees, Angela Packham, et al. · Poster presentations
P397 Can upskilling pharmacy technicians support a robust and cost-effective Inflammatory Bowel Disease patient review process? A single-centre prospective study
2022 · F Rees, A Packham, et al. · Journal of Crohn s and Colitis
Works count: 32
Citation count: 60
H-index: 4
I10-index: 1
Year
Topic
Type